Bicistronic CAR T-cells Against CD70 & Active Integrin β2 Overcome Antigen Heterogeneity and Preserve Safety in Acute Myeloid Leukemia
Amrik S. Kang(University of California, San Francisco), Arun P. Wiita(University of California, San Francisco)
Cited by 0
Related Papers
Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target
|Nature Cancer|2023|36
A CRISPR-engineered isogenic model of the 22q11.2 A-B syndromic deletion
|Scientific Reports|2023|10
Integrated Phosphoproteomics and Transcriptional Classifiers Reveal Hidden RAS Signaling Dynamics in Multiple Myeloma
|bioRxiv (Cold Spring Harbor Laboratory)|2019|4
A CRISPR-engineered Isogenic Model Reveals Altered Neuronal Phenotypes of the 22q11.2 A-B Syndromic Deletion
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2
Time-resolved proteomics vs. ribosome profiling reveals translation dynamics under stress
|bioRxiv (Cold Spring Harbor Laboratory)|2016|0